We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Switching to the Dry-Powder Inhaler Easyhaler<sup>®</sup>: A Narrative Review of the Evidence.
- Authors
Lavorini, Federico; Chudek, Jerzy; Gálffy, Gabriella; Pallarés-Sanmartin, Abel; Pelkonen, Anna S.; Rytilä, Paula; Syk, Jörgen; Szilasi, Maria; Tamási, Lilla; Xanthopoulos, Athanasios; Haahtela, Tari
- Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a substantial contributing factor to the suboptimal clinical control of both conditions. The practicality, dependability, and acceptability of different inhalers influence the overall effectiveness and success of inhalation therapy. In this paper, experts from various European countries (Finland, Germany, Hungary, Italy, Poland, Spain, and Sweden) address inhaler selection with special focus on the Easyhaler® device, a high- or medium–high resistance dry-powder inhaler (DPI). The evidence examined indicates that use of the Easyhaler is associated with effective control of asthma or COPD, as shown by the generally accepted indicators of treatment success. Moreover, the Easyhaler is widely accepted by patients, is reported to be easy to learn and teach, and is associated with patient adherence. These advantages help patient education regarding correct inhaler use and the rational selection of drugs and devices. We conclude that switching inhaler device to the Easyhaler may improve asthma and COPD control without causing any additional risks. In an era of climate change, switching from pressurized metered-dose inhalers to DPIs is also a cost-effective way to reduce emissions of greenhouse gases. 5TEfF4YsHYx_1PQHoqCf7D Enhanced feature (slides, video, animation) (MP4 43768 kb)
- Subjects
METERED-dose inhalers; INHALERS; RESPIRATORY therapy; OBSTRUCTIVE lung diseases; PHYSICIANS
- Publication
Pulmonary Therapy, 2021, Vol 7, Issue 2, p409
- ISSN
2364-1746
- Publication type
Article
- DOI
10.1007/s41030-021-00174-5